TMEM9B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.949000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.035200E-01
Normal-vs-Stage2
6.290400E-01
Normal-vs-Stage3
8.475200E-01
Normal-vs-Stage4
3.168400E-01
Stage1-vs-Stage2
6.541800E-01
Stage1-vs-Stage3
3.821400E-01
Stage1-vs-Stage4
5.732400E-01
Stage2-vs-Stage3
4.075600E-01
Stage2-vs-Stage4
2.379000E-01
Stage3-vs-Stage4
2.441200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.045800E-01
Normal-vs-AfricanAmerican
6.353200E-01
Normal-vs-Asian
8.325200E-01
Caucasian-vs-AfricanAmerican
9.459200E-01
Caucasian-vs-Asian
5.613200E-01
AfricanAmerican-vs-Asian
7.336800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.161800E-01
Normal-vs-Female
7.304400E-01
Male-vs-Female
1.306360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.728600E-01
Normal-vs-Age(41-60Yrs)
4.820000E-01
Normal-vs-Age(61-80Yrs)
6.679200E-01
Normal-vs-Age(81-100Yrs)
6.584400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.550200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.248400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.408600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.105800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.072400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.854800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.926800E-01
Normal-vs-Daily Drinker
6.655400E-01
Normal-vs-Weekly Drinker
8.703600E-01
Normal-vs-Occasional Drinker
1.704210E-01
Normal-vs-Social Drinker
7.731200E-01
Non Drinker-vs-Daily Drinker
6.377200E-01
Non Drinker-vs-Weekly Drinker
4.306600E-01
Non Drinker-vs-Occasional Drinker
3.255600E-02
Non Drinker-vs-Social Drinker
8.166600E-01
Daily Drinker-vs-Weekly Drinker
2.920200E-01
Daily Drinker-vs-Occasional Drinker
1.438000E-01
Daily Drinker-vs-Social Drinker
4.906800E-01
Weekly Drinker-vs-Occasional Drinker
1.381780E-02
Weekly Drinker-vs-Social Drinker
5.101400E-01
Occasional Drinker-vs-Social Drinker
1.213640E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.236000E-02
Normal-vs-Grade 2
5.575800E-03
Normal-vs-Grade 3
5.136500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.721390E-01
Grade 1-vs-Grade 3
4.595600E-01
Grade 1-vs-Grade 4
2.236000E-02
Grade 2-vs-Grade 3
4.737600E-01
Grade 2-vs-Grade 4
5.575800E-03
Grade 3-vs-Grade 4
5.136500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.518200E-01
Normal-vs-NonDiabetic
6.658400E-01
Diabetic-vs-NonDiabetic
7.985000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.193200E-01
Normal-vs-NoPancreatitis
6.625800E-01
Pancreatitis-vs-NoPancreatitis
4.020800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.025800E-01
Normal-vs-N1
6.784000E-01
N0-vs-N1
8.291600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.290000E-01
Normal-vs-TP53-NonMutant
5.976400E-01
TP53-Mutant-vs-TP53-NonMutant
1.246970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
